Moderna stock gains after a 6.7 percent jump

Published on 09/11/2026 at 23:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Moderna stock traded up 6.7 percent to USD 145.71 on September 11, 2026. MarketBeat also showed a USD 54.54 billion market cap and a hold consensus.

Aquarellmalerei der Cambridge-Skyline mit modernen Forschungsgebäuden am Charles River — Moderna Inc. (US60770K1034) präsentiert eine stimmungsvolle Aquarell-Ansicht der Cambridge-Skyline mit modernen Biotech-Forschungsgebäuden am Flussufer, Illustration mit AI erstellt.

Moderna stock (ISIN US60770K1034) traded up 6.7 percent on September 11, 2026, and last changed hands at USD 145.71, after touching an intraday high of USD 141.10 in one market snapshot and USD 147.97 in another. MarketBeat put the market capitalization at USD 54.54 billion and the 52-week range at USD 22.28 to USD 176.66.

Analysts stay cautious

According to MarketBeat, Moderna has a consensus rating of Hold and a consensus price target of USD 76.72, which is 43.8 percent below the quoted price on September 10, 2026. The same page lists 24 analysts, 7 Buy ratings, 12 Hold ratings and 5 Sell ratings.

According to MarketBeat, Moderna reported USD 145.00 million in revenue for the quarter ended July 31, 2026, versus analyst estimates of USD 102.93 million, while earnings per share came in at USD -1.97 versus a consensus of USD -2.03. The report also said revenue rose 2.1 percent year over year and that the company still had a negative net margin of 141.43 percent.

July 31 numbers matter

Moderna stock was also trading above its 50-day average of USD 91.07 and 200-day average of USD 66.19 on September 10, 2026, which keeps the chart far above the levels seen earlier in the year. The same MarketBeat page showed 7.86 million shares of volume and an average daily volume of 33.45 million shares.

Price and setup

At the close on September 10, 2026, Moderna stock stood at USD 136.62 on Nasdaq, up 0.74 percent for the session, with a day range of USD 133.20 to USD 137.40 and volume of 9.3 million shares, according to ad hoc news. For investors, the key comparison is clear: the stock price is trading well above the July 31 quarterly revenue base of USD 145.00 million and far above the consensus target of USD 76.72.